Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →

More filters
Clear filters

HALO · 50 trades

Trades
50
Buys 2 · Sells 48
People
7
Stocks
1
Disclosed value
$23.7M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLGilbert Ray Cisneros Jr Dem · House · CAHALO Halozyme Therapeutics, Inc.$1K–$15Kdisclosed Oct 9 · filed 10 days after the trade
  2. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$22.7Kdisclosed Oct 8 · filed 1 day after the trade
  3. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$248Kdisclosed Oct 8 · filed 2 days after the trade
  4. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$102Kdisclosed Oct 8 · filed 1 day after the trade
  5. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$337Kdisclosed Oct 8 · filed the same day
  6. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.2Mdisclosed Oct 8 · filed 1 day after the trade
  7. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$22.1Kdisclosed Oct 8 · filed the same day
  8. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.1Mdisclosed Oct 8 · filed 2 days after the trade
  9. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$955Kdisclosed Oct 8 · filed 1 day after the trade
  10. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$520Kdisclosed Oct 8 · filed the same day
  11. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.3Mdisclosed Oct 8 · filed the same day
  12. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$197Kdisclosed Oct 8 · filed 2 days after the trade
  13. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$656Kdisclosed Oct 8 · filed 2 days after the trade
  14. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$11Kdisclosed Oct 2 · filed 1 day after the trade
  15. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$78.2Kdisclosed Oct 2 · filed 1 day after the trade
  16. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$358Kdisclosed Oct 2 · filed 1 day after the trade
  17. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$121Kdisclosed Oct 2 · filed 1 day after the trade
  18. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$961Kdisclosed Sep 17 · filed 1 day after the trade
  19. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$320Kdisclosed Sep 17 · filed 1 day after the trade
  20. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$436Kdisclosed Sep 17 · filed 1 day after the trade
  21. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$329Kdisclosed Sep 17 · filed 1 day after the trade
  22. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$485Kdisclosed Sep 11 · filed the same day
  23. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.4Mdisclosed Sep 11 · filed 2 days after the trade
  24. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$582Kdisclosed Sep 11 · filed 1 day after the trade
  25. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.6Mdisclosed Sep 11 · filed 1 day after the trade